logo

Shanghai ChemPartner Opens European Headquarters
By: China Bio Today   Monday, October 19, 2009 3:19 PM

Vote for next session
The next market session will close:

Next month, CRO Shanghai ChemPartner will open a European headquarters office in Denmark that will be known as ChemPartner Europe ApS. The office, which will function as a liaison to Europe's biopharma industry, will be sited in Scion Research Park in Hørsholm, in the outskirts of Copenhagen. This area is called Medicon Valley and is home to many pharmas and service companies.

As CEO, ChemPartner Europe has hired Peter Halkjær-Knudsen, who has more than 20 years of experience working in biotech companies from several countries.

Part of the reason for opening in Denmark was the established biopharma industry there as well as the ease of establishing a company in Denmark. Also, Halkjær-Knudsen said the Chinese appreciate the efficiency and quickness of the Danes.

With more that 1200 scientific employees, Shanghai ChemPartner offers specialized expertise in cancer, diabetes and arthritis. The company was founded in 2003 and counts over 60 biopharma clients from around the world.

(0)
No Comments
Post Comment
Name:  
Alert for new comments:
Your email:
Your Website:
Title:
Comments:
   
 
 
 
 
   
 

The above story is the opinion of the author only and it does not reflect iStockAnalyst opinion. Further, the author is not personally advising you regarding the suitability of the story for your investment needs. In no event iStockAnalyst will be liable for any loss or damage including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from or arising out of, or in connection with the use of this information. Please consult your investment advisor before making any investment decision.
  
Advertisement
Popular Articles
Related Press Releases
Partner Center
Recent Articles by China Bio Today



Subscribe to Email Alerts rss feed or RSS feeds rss feed for articles from more than 500 contributors, press releases, SEC filings and full text news from more than four thousand sources.
Fundamental data is provided by Zacks Investment Research, market data is provided by AlphaTrade. , and Commentary and Press Releases provided by Quotemedia